295 related articles for article (PubMed ID: 27376675)
1. RNA-based therapies for genodermatoses.
Bornert O; Peking P; Bremer J; Koller U; van den Akker PC; Aartsma-Rus A; Pasmooij AM; Murauer EM; Nyström A
Exp Dermatol; 2017 Jan; 26(1):3-10. PubMed ID: 27376675
[TBL] [Abstract][Full Text] [Related]
2. RNA Therapeutics: How Far Have We Gone?
Coutinho MF; Matos L; Santos JI; Alves S
Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.
Du L; Gatti RA
J Immunol Methods; 2011 Feb; 365(1-2):1-7. PubMed ID: 21147113
[TBL] [Abstract][Full Text] [Related]
4. RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger B; Piñón Hofbauer J; Wally V; Arzt C; Hainzl S; Kocher T; Murauer EM; Bauer JW; Reichelt J; Koller U
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518954
[TBL] [Abstract][Full Text] [Related]
5. Innovative developments and emerging technologies in RNA therapeutics.
Halloy F; Biscans A; Bujold KE; Debacker A; Hill AC; Lacroix A; Luige O; Strömberg R; Sundstrom L; Vogel J; Ghidini A
RNA Biol; 2022; 19(1):313-332. PubMed ID: 35188077
[TBL] [Abstract][Full Text] [Related]
6. Current developments in gene therapy for epidermolysis bullosa.
Kocher T; Petkovic I; Bischof J; Koller U
Expert Opin Biol Ther; 2022 Sep; 22(9):1137-1150. PubMed ID: 35235467
[TBL] [Abstract][Full Text] [Related]
7. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
[TBL] [Abstract][Full Text] [Related]
8. Research on genodermatoses using novel genome-editing tools.
Lehmann J; Seebode C; Emmert S
J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
[TBL] [Abstract][Full Text] [Related]
9. Splice-switching antisense oligonucleotides as therapeutic drugs.
Havens MA; Hastings ML
Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
[TBL] [Abstract][Full Text] [Related]
10. RNA trans-splicing for genodermatoses.
Bauer JW; Murauer EM; Wally V; Koller U
Methods Mol Biol; 2013; 961():441-55. PubMed ID: 23325663
[TBL] [Abstract][Full Text] [Related]
11. MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction.
Behrens-Gawlik V; Mearini G; Gedicke-Hornung C; Richard P; Carrier L
Pflugers Arch; 2014 Feb; 466(2):215-23. PubMed ID: 24337823
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo gene modification therapy for genetic skin diseases-recent advances in gene modification technologies and delivery.
Jayarajan V; Kounatidou E; Qasim W; Di WL
Exp Dermatol; 2021 Jul; 30(7):887-896. PubMed ID: 33657662
[TBL] [Abstract][Full Text] [Related]
13. Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets.
Barresi V; Musmeci C; Rinaldi A; Condorelli DF
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012138
[TBL] [Abstract][Full Text] [Related]
14. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
Kaczmarek JC; Kowalski PS; Anderson DG
Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
Isidoro-García M; Dávila I
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
[TBL] [Abstract][Full Text] [Related]
16. Gene and splicing therapies for neuromuscular diseases.
Benchaouir R; Robin V; Goyenvalle A
Front Biosci (Landmark Ed); 2015 Jun; 20(8):1190-233. PubMed ID: 25961553
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular diagnosis of genodermatoses: Review and perspectives.
Salik D; Richert B; Smits G
J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):488-500. PubMed ID: 36502512
[TBL] [Abstract][Full Text] [Related]
18. Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers.
Maruyama R; Yokota T
Methods Mol Biol; 2020; 2176():49-56. PubMed ID: 32865781
[TBL] [Abstract][Full Text] [Related]
19. Challenges and Opportunities for Nucleic Acid Therapeutics.
Corey DR; Damha MJ; Manoharan M
Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
[TBL] [Abstract][Full Text] [Related]
20. Trans-splicing improvement by the combined application of antisense strategies.
Koller U; Hainzl S; Kocher T; Hüttner C; Klausegger A; Gruber C; Mayr E; Wally V; Bauer JW; Murauer EM
Int J Mol Sci; 2015 Jan; 16(1):1179-91. PubMed ID: 25569093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
